SERBP1 is required for efficient HR repair and cisplatin chemoresistance in lung adenocarcinoma. [PDF]
Xie Y +10 more
europepmc +1 more source
At the Right Time: Temporal Precision in Personalised Medicine
ABSTRACT Personalised medicine was initially heralded as delivering ‘the right drug to the right patient at the right time’. Although molecular precision has dominated recent developments, the temporal dimension has remained underexplored. This paper examines how temporal precision is emerging as a defining feature of next‐generation precision medicine,
Dominik Hofmann, Elena Esposito
wiley +1 more source
From mutation to treatment: The dual role of BRCA1 and BRCA2 in gynecological malignancy development and management a systematic review. [PDF]
Georgy DM +6 more
europepmc +1 more source
MEX3A, a pivotal RNA‐binding protein (RBP), which is activated by copy number amplification at the genomic level and regulated by the transcription factor c‐Myc at the transcriptional level, functions as a potential therapeutic target for overcoming TKI resistance in NSCLC. ABSTRACT Objective To investigate the functional role and activation mechanisms
Shi Xiling +7 more
wiley +1 more source
BARD1 recognizes pre-rRNA for DNA damage repair and rRNA biogenesis. [PDF]
Huang H, Wu D, Yu X.
europepmc +1 more source
Neurons expressing APOE2 were more resistant to endogenous DNA damage, activated transcriptional signaling pathways associated with DNA repair, and were resilient to stress‐induced DNA damage and cellular senescence. In contrast, APOE4 neurons exhibited elevated expression of rRNA repetitive elements and were prone to becoming senescent.
Cristian Gerónimo‐Olvera +20 more
wiley +1 more source
Cryptic redundancy between PAR1b and PAR1a, two members of the PAR1 kinase family, in the survival of PAR1b-knockout mice. [PDF]
Murata-Kamiya N +3 more
europepmc +1 more source
Aging‐Driven Immunosuppression: The Role of Tregs in the Ovarian Tumor Microenvironment
In the aged ovarian TME, cancer cells exhibit increased succinate production. Elevated extracellular succinate activates the SUCNR1 receptor on Tregs, promoting their recruitment and contributing to an immunosuppressive environment. This leads to diminished anti‐tumor T cell responses and reduced survival.
Mary P. Udumula +10 more
wiley +1 more source
Resistance to neoadjuvant talazoparib in triple-negative breast cancer by BRN2-induced ATR/STAT3 pathways or SHLD2 subclone expansion. [PDF]
Abdulkareem NM +14 more
europepmc +1 more source
Opioids in breast cancer: Between analgesia and modulation of tumour progression
Preclinical investigations consistently demonstrate that activation of μ‐opioid receptors and δ‐opioid receptors promote proliferation, migration, angiogenesis, epithelial‐mesenchymal transition, acquisition of cancer stem cell phenotypes, and chemoresistance.
Marianna Ciwun +2 more
wiley +1 more source

